CLASS II ONGOING Drug recall · Reported 4 Nov 2026 · FDA Enforcement Report

Abiraterone Acetate Tablets USP 500 mg recalled

Glenmark Pharmaceuticals Inc., USA is recalling Abiraterone Acetate Tablets USP 500 mg, distributed nationwide in the US. The recall was initiated on 9 Oct 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 13250135, Exp. Date 11/2027
NDC68462-135, 68462-882
UPC0368462882603
Quantity recalled1296 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0074-2027
FDA event ID
100128
Recalling firm
Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Classification
Class II
Status
Ongoing
Recall initiated
9 Oct 2026
FDA classified
23 Oct 2026
Reported
4 Nov 2026
Type
Voluntary: Firm initiated
Reason category
Foreign Material

Timeline

9 Oct 2026Recall initiated by company
23 Oct 2026Classified by FDA+14 days
4 Nov 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Not Elsewhere Classified

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Not Elsewhere Classified

Which lots are affected?

Lot #: 13250135, Exp. Date 11/2027

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 10 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Glenmark Pharmaceuticals Inc., USA

All 142

Other Abiraterone recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAbirtega (abiraterone acetate) USP, 250 mg recalledAbirtegaHikma Pharmaceuticals USAOtherNationwide